Lipid-lowering drugs Flashcards
_____ are the mainstay of treatment of hyperlipidemia
Statin
_____ and to a lesser extent Lovastatin and Simvastatin may need adjustments in renal pts.
Pravastatin
Side effects of Niacin
Most common: intense prostaglandin-induced cutaneous flushing in ~ 10% of pts ASA 30 min before ingestion of niacin decreases flushing Abd pain, N/V/D Malaise Large doses: Hepatic dysfunction; jaundice Do not give to pts with hx of liver disease Hyperglycemia and abnormal glucose tolerance may occur in non diabetic pts on niacin Increased uric acid concentrations in plasma Increase in incidence of gouty arthritis May exaggerate orthostatic hypotension associated with antihypertensive drugs and myopathy associated statins PUD can be reactivated by niacin
Metabolized by CYP2C9 and have lowest rate of events.
Fluvastatin and rosuvastatin
Statin side effect
Most Common Complaints: GI, Fatigue, Headache. Clinical trial = < 5% experience adverse side effects (vs. placebo). Incidence in general population is thought to be higher. Most Common Adverse Side Effects: Range from simple myalgias to myositis with mild creatine kinase (CK) elevation to life-threatening rhabdomyolysis (>10-fold elevation of CK) Myositis and rhabdomyolysis are rare. Myalgias are reported in as many as 1/3 of statin users: See table 23-4 p545 Risk factors Myotoxicity Possibly caused by inhibiting HMG-CoA reductase. Statins decrease cholesterol synthesis and the formation of ubiquinone (coenzyme Q10) which is important for mitochondrial function and cell membrane integrity
Hepatic cholesterol synthesis and its distribution to the peripheral tissues
Endogenous
_________ can decrease absorption of statins
Bile acid-binding resins
Statin drugs
Atorvastatin Fluvastatin Lovastatin Pravastatin Simvastatin Rosuvastatin
Bile and Resin drugs
Colesevelam Cholestyramine Colestipol
Statin moa Inhibits __________(the enzyme that catalyzes the rate-limiting step of cholesterol biosynthesis) Structurally related to HMG-CoA and competitive inhibition of the enzyme causes increase in hepatic LDL-R.
HMG-CoA reductase
EXOGENOUS PATHWAY
Small Intestines: Bile emulsifies dietary fat and cholesterol Pancreas: Hydrolyzes triglycerides Intestinal endothelium takes up these products by endocytosis and packages lipids into large chylomicrons, which then enter the lymphatic system Chylomicrons → travel through thoracic duct enter blood stream interaction with lipoprotein lipase (LPL) in vascular endothelial cells yields glycerol and free fatty acids these can be utilized by peripheral tissues for fuel or storage. During this process chylomicrons shrink and become chylomicron remnants. Remnants transport to liver taken up by hepatocytes via endocytosis then hydrolyzed
Prodrugs. Require metabolism to the open β-hydroxyl acid form to be pharmacologically active
Lovastatin, Simvastatin
↑ LDL associated with ↑ risk of _____
CV disease
naturally occurring. Isolated from a strain of Aspergillus terreus.
Lovastatin
Niacin Primary Route of Metabolism is __________
Methylation to N-methyl-nicotinamide
Hyperlipidemia may also arise from secondary causes:
Obesity Diabetes Alcohol abuse Hypothyroidism Glucocorticoid excess Hepatic or renal dysfunction
Homozygotes more rare: total LDL cholesterol levels 4 x normal and have extreme propensity for ________
atherosclerosis